(Q34960850)

English

Toremifene increases bone mineral density in men receiving androgen deprivation therapy for prostate cancer: interim analysis of a multicenter phase 3 clinical study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

5 August 2017

Toremifene increases bone mineral density in men receiving androgen deprivation therapy for prostate cancer: interim analysis of a multicenter phase 3 clinical study (English)

1 reference

Europe PubMed Central

5 August 2017

multicenter clinical trial

0 references

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

M R Smith

1

1 reference

Europe PubMed Central

5 August 2017

S B Malkowicz

2

1 reference

Europe PubMed Central

5 August 2017

F Chu

3

1 reference

Europe PubMed Central

5 August 2017

J Forrest

4

1 reference

Europe PubMed Central

5 August 2017

D Price

5

1 reference

Europe PubMed Central

5 August 2017

P Sieber

6

1 reference

Europe PubMed Central

5 August 2017

K G Barnette

7

1 reference

Europe PubMed Central

5 August 2017

D Rodriguez

8

1 reference

Europe PubMed Central

5 August 2017

M S Steiner

9

1 reference

Europe PubMed Central

5 August 2017

language of work or name

0 references

publication date

14 November 2007

1 reference

Europe PubMed Central

5 August 2017

Journal of Urology

1 reference

Europe PubMed Central

5 August 2017

179

1 reference

Europe PubMed Central

5 August 2017

1

1 reference

Europe PubMed Central

5 August 2017

152-155

1 reference

Europe PubMed Central

5 August 2017

The rising prevalence of androgen deprivation among older American men since the advent of prostate-specific antigen testing: a population-based cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090686

8 July 2018

Toremifene: an evaluation of its safety profile

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090686

8 July 2018

Androgen deprivation therapy for prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090686

8 July 2018

Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090686

8 July 2018

Vitamin D receptor genotypes are related to bone size and bone density in men.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090686

8 July 2018

17 beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090686

8 July 2018

Insulin sensitivity during combined androgen blockade for prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090686

26 October 2018

Raloxifene to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer: a randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090686

26 October 2018

Estrogenic effects of toremifene and tamoxifen in postmenopausal breast cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090686

26 October 2018

Changes in body composition during androgen deprivation therapy for prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090686

26 October 2018

Pamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090686

26 October 2018

Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090686

26 October 2018

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090686

26 October 2018

The incidence of vertebral fractures in men and women: the Rotterdam Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18001802

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bone mineral density in men treated with synthetic gonadotropin-releasing hormone agonists for prostatic carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18001802

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A controlled trial of raloxifene (LY139481) HCl: impact on bone turnover and serum lipid profile in healthy postmenopausal women

1 reference

https://pubmed.ncbi.nlm.nih.gov/18001802

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Skeletal fractures negatively correlate with overall survival in men with prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18001802

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective estrogen receptor modulators to prevent treatment-related osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18001802

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum lipid levels during and after adjuvant toremifene or tamoxifen therapy for breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18001802

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women

1 reference

https://pubmed.ncbi.nlm.nih.gov/18001802

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18001802

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.JURO.2007.08.137

1 reference

Europe PubMed Central

5 August 2017

1 reference

Europe PubMed Central

5 August 2017

1 reference

Europe PubMed Central

5 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34960850&oldid=1980119566"